Medication info

Megapibatine Tablet 2 mg (Pitavastatin Calcium)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
LNC Bio Co., Ltd.
Appearance
Very light yellowish-red, round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202001859 · Approved 2020.03.17

This product's status changed to Approval withdrawn on 2024.09.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium orally once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased up to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
LNC Bio Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • dyslipidemia
  • elevated total cholesterol
  • LDL cholesterol
  • Apo-B protein
  • triglycerides
View approved original text

This medication helps control blood lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia. Specifically, it lowers total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels, while increasing HDL cholesterol, which is good cholesterol. This plays a significant role in maintaining cardiovascular health. The effect is further enhanced when used alongside dietary therapy, improving the balance of blood lipids. Therefore, this medication is effectively used in the treatment of hyperlipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium orally once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased up to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication should not be used in patients with allergies to specific ingredients or who have liver function issues. It may be risky to take for patients with active liver disease or consistently elevated liver enzymes, as well as those with severe liver impairment or bile duct obstruction. Patients taking cyclosporine or those with myopathy, pregnant or possibly pregnant women, breastfeeding women, and children should not be given this medication. Patients with renal dysfunction or a history of liver issues should use this medication cautiously, especially if used with fibrate medications or niacin, as there may be risks of muscle damage and worsening renal function. Older adults may also experience adverse reactions more readily when taking this medication. Adverse reactions such as myalgia, weakness, skin rash, itching, dyspepsia may occur when taking this medication, and rhabdomyolysis, where muscle tissue breaks down, can occur rarely; if symptoms of muscle pain or weakness appear, medical consultation should be sought immediately. Liver dysfunction, thrombocytopenia, allergic reactions, etc. may also occur, necessitating regular blood tests and liver function tests. As this medication is used to treat hyperlipidemia, it is essential to check blood lipid levels before administration and conduct regular tests during administration to evaluate the treatment's effectiveness. Patients with weak liver function may require dose adjustments and regular liver function tests must be performed during treatment. This medication can interact with other drugs, so caution is especially needed when taken with cyclosporine, fibrate medications, niacin, or erythromycin, and if symptoms like myalgia or weakness occur during combined usage, administration should be stopped immediately. This medication is not used in pregnant or breastfeeding individuals, and if pregnancy is confirmed, administration should be stopped immediately. Its safety and efficacy in children have not been established, so it is not used in pediatric patients. This medication should be kept out of reach of children and stored in its original container. Older adults and those with renal or liver dysfunction are at increased risk of adverse reactions and should take this medication with caution.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • numbness
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 76 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • hives
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • feeling of heaviness in the head
  • dizziness
  • dry mouth
  • dyspepsia
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • increased frequency of urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • elevated aldosterone
  • elevated adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • feeling of limpness
  • palpitations
  • fatigue
  • dermal pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • elevated serum potassium and phosphorus
  • taste disorders
  • positive antinuclear antibody
  • facial edema
  • arm edema
  • hypersensitivity
  • skin paresthesia
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes mellitus
  • immune-mediated necrotizing myopathy

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container that can block light, at a temperature between 1 and 30 degrees Celsius. Proper storage ensures the medication's effectiveness is maintained and prevents degradation.

Appearance and packaging

Appearance

Very light yellowish-red, round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.